Work

Combination Therapy with Amprenavir, Abacavir, and Efavirenz in Human Immunodeficiency Virus (HIV)-Infected Patients Failing a Protease-Inhibitor Regimen: Pharmacokinetic Drug Interactions and Antiviral Activity

Year: 2000

Type: article

Study design: Clinical Trial

Source: Clinical Infectious Diseases

DOI: 10.1086/313667

Authors: J. Falloon, S. Piscitelli, S. Vogel, B. Sadler, H. Mitsuya, M. F. Kavlick, K. Yoshimura, M. Rogers, S. LaFon, D. J. Manion, H. C. Lane, H. Masur

Institutions: National Institutes of Health, National Institute of Allergy and Infectious Diseases, National Cancer Institute, DuPont (United States)

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institute of Allergy and Infectious Diseases

OpenAlex ID: W2146240795

FWCI: 8.592

Cites: 14

Cited by: 76

Related to: 10